Last reviewed · How we verify

NCT04402372

Novel Bidirectional Peripheral Artery Cannula in Minimally Invasive Aortic Valve Surgery

Status unknown Last updated 26 May 2020
What this trial tests

trial testing Novel bidirectional cannula (BiflowTM, LivaNova, Italy) in Efficacy and Safety of Novel Bidirectional Cannula in 60 participants. Status unknown.

Timeline
1 March 2020
Primary endpoint
15 June 2020
15 June 2020

Quick facts

Lead sponsorAnkara City Hospital Bilkent
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment60
Start date1 March 2020
Primary completion15 June 2020
Estimated completion15 June 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ankara City Hospital Bilkent

Who can join

Adults 50 to 90, any sex, with Efficacy and Safety of Novel Bidirectional Cannula. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the safety and efficacy of the novel bidirectional cannula (BiflowTM, LivaNova, Italy) with specific design to ensure stable distal perfusion compared to conventional cannula with downstream line in patients undergoing femoral arterial cannulation for cardiopulmonary bypass during minimally invasive surgery

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Ankara City Hospital Bilkent trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04402372.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing